The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Find out about Merck's hepatitis drug that is also being tested for HCV/HIV co-infection, liver cirrhosis and more in a clinical trial program.
Continue reading »
A potential new treatment for Hepatitis C that will shorten treatment time and work on all genotypes is expected in 2018.
Continue reading »
Find out about a new web and mobile app that provides self-care tools for people living with chronic Hepatitis C.
Continue reading »
Study indicates HCV patients 2.5 times more likely to be diagnosed with cancer, including liver cancer. When liver cancer was excluded, cancer risk was still about 2 times higher for HCV patients.
Continue reading »
Adolescents and young adults who inject crushed painkiller pills is on the rise...and so is Hepatitis C.
Continue reading »
A recent VA memo recommends urgently treating those with advanced liver disease, but holding off for patients with mild cases of the illness.
Continue reading »
The World Health Organization updated its Essential Medicines List to include five drugs used to treat hepatitis C.
Continue reading »
Learn more about Bristol-Myers Squibb’s drugs that had a 93% cure rate in recent trials for Hepatitis C genotype 1.
Continue reading »
New daclatasvir/sofosbuvir/ribavirin treatment showing promising trial results.
Continue reading »
Learn more about grazoprevir/elbasvir, Merck's Hepatitis C drug that has been fast-tracked for FDA approval.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
